Jullian G. Jones's most recent trade in Monte Rosa Therapeutics Inc was a trade of 79,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 2, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Monte Rosa Therapeutics Inc | Jullian G. Jones | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 79,000 | 79,000 | - | - | Stock Option (Right to Buy) | |
| Monte Rosa Therapeutics Inc | Jullian G. Jones | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 77,450 | 77,450 | - | - | Stock Option (Right to Buy) | |
| Monte Rosa Therapeutics Inc | Jullian G. Jones | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 73,300 | 73,300 | - | - | Stock Option (Right to Buy) |